SCHEMBL19088501

SCHEMBL19088501

CN[C@@H](CC(C)(C)F)C(=O)O[C@H](Cc1ccc(C2=CCOCC2)cc1)C(=O)OCc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.36
PPARG P37231 4/20 0.34
PPARA Q07869 4/20 0.34
NAAA Q02083 4/20 0.34
BRD4 O60885 1/20 0.34
CTSC P53634 1/20 0.34
SRR Q9GZT4 1/20 0.33
PSAT1 Q9Y617 1/20 0.33
MME P08473 1/20 0.33
ACE P12821 1/20 0.33
CTSL P07711 3/20 0.33
CTSB P07858 1/20 0.33
CTSF Q9UBX1 1/20 0.33
CTSK P43235 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24297805 0.95 AAK1 (0.38) AAK1NAAACTSC
SCHEMBL21266633 0.92 AAK1 (0.35) AAK1PPARANAAABRD4CTSB
SCHEMBL19088567 0.90 AAK1 (0.39) AAK1PPARGPPARACTSCSRR
SCHEMBL19088575 0.88 CTSL (0.32) AAK1CTSLCTSBCTSK
SCHEMBL18248177 0.83 ITGB3 (0.34) AAK1BRD4CTSK
SCHEMBL23279554 0.83 ITGB3 (0.34) AAK1BRD4CTSK
SCHEMBL18256349 0.83 ITGB3 (0.34) AAK1BRD4CTSK
SCHEMBL21159528 0.83 CTSL (0.32) CTSLCTSBCTSK
SCHEMBL23279516 0.81 PPARG (0.41) PPARGPPARABRD4CTSCSRR
SCHEMBL19088506 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018048-B2 Anthelmintic depsipeptide compounds Boehringer Ingelheim Animal Health USA Inc. (US) 2024-06-25 US disclosed
US-12018048-B2 Anthelmintic depsipeptide compounds Boehringer Ingelheim Animal Health USA Inc. (US) 2024-06-25 US disclosed
EP-3397638-B1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC (US) 2023-08-23 EP disclosed
EP-3397638-B1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC (US) 2023-08-23 EP disclosed
US-20220098241-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS Boehringer Ingelheim Animal Health USA Inc. (US) 2022-03-31 US disclosed
US-20220098241-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS Boehringer Ingelheim Animal Health USA Inc. (US) 2022-03-31 US disclosed
US-11230571-B2 Anthelmintic depsipeptide compounds Boehringer Ingelheim Animal Health USA Inc. (US) 2022-01-25 US disclosed
US-20190248840-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS Boehringer Ingelheim Animal Health USA Inc. (US) 2019-08-15 US disclosed
US-10344056-B2 Anthelmintic depsipeptide compounds Boehringer Ingelheim Animal Health USA Inc. (US) 2019-07-09 US disclosed
US-20170233438-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS MERIAL INC. (US) 2017-08-17 US disclosed
US-20170233438-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS MERIAL INC. (US) 2017-08-17 US disclosed
WO-2017116702-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS MERIAL, INC. (US) 2017-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10344056-B2 Anthelmintic depsipeptide compounds VIP, PREP, DNPEP AAK1 3436/4885PPARG 3670/4885PPARA 3876/4885
US-12018048-B2 Anthelmintic depsipeptide compounds VIP, DNPEP, DPEP1 AAK1 3150/4885PPARG 3029/4885PPARA 3307/4885
US-20170233438-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS VIP, PREP, DNPEP AAK1 3436/4885PPARG 3670/4885PPARA 3876/4885
US-20220098241-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS VIP, PREP, DNPEP AAK1 3436/4885PPARG 3670/4885PPARA 3876/4885
US-20190248840-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS VIP, PREP, DNPEP AAK1 3436/4885PPARG 3670/4885PPARA 3876/4885
US-11230571-B2 Anthelmintic depsipeptide compounds VIP, PREP, DNPEP AAK1 3436/4885PPARG 3670/4885PPARA 3876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.